Deep androgen receptor suppression in prostate cancer exploits sexually dimorphic renal expression for systemic glucocorticoid exposure
Mohammad Alyamani, J. Li, Monaben Patel, Sarah Taylor, Fumihiko Nakamura, Michael Berk, Christopher G. Przybycin, Edwin M. Posadas, Ravi A. Madan, James L. Gulley, Brian I. Rini, J. Garcia, Eric A. Klein, Nima Sharifi
Topics & Concepts
MedicineProstate cancerGlucocorticoid receptorAndrogen receptorGlucocorticoidAndrogenSexual dimorphismInternal medicineEndocrinologyEnzalutamideOncologyCancer researchCancerHormoneProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentCancer, Lipids, and Metabolism